Company profile
BeyondSpring Inc.
NASDAQ: BYSI · Healthcare · Biotechnology
PublicHQ Florham Park, NYCIK 0001677940Reports USD
#1163 of 1,418 Healthcare companies by revenue
EA Score
34DFH 32DQ 45GM 8SS 50
v0.1 · 65/100 weight · provisional
↑ return on assets, market scale · ↓ 3-yr revenue growth, Piotroski F
Methodology →Revenue TTM
$0
Rev growth YoY (TTM)
-100.0%
Net income (FY)
-$1.0M
Employees
44
as of 2026-09-16
Market cap
$30.9M
as of 2026-09-16
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$0$02025
Net income-$1.0M-$1.0M2025
Operating income-$8.9M-$8.9M2025
Total assets$25.9M$25.9M2025
Liabilities$49.9M$49.9M2025
Equity-$32.2M-$32.2M2025
Revenue trend
FY2018 – FY2025 · USD
FY18
FY19
FY20
FY21
FY22
FY24
FY24
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is BeyondSpring Inc.’s revenue?
BeyondSpring Inc. booked $0 in FY2025 revenue — among the slowest-growing Healthcare companies we track, at a -Infinity% net margin.
Peers · Healthcare
NanoViricides, Inc.35DLite Strategy, Inc.49DGrace Therapeutics, Inc.48DBarinthus Biotherapeutics plc39DSona Nanotech Inc.——High Sierra Technologies, Inc.——Key facts
CEOQiu Min
SectorHealthcare
IndustryBiotechnology
HeadquartersFlorham Park, NY
ExchangeNASDAQ: BYSI
Employees44
IPO date2017-03-09
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.